More about Procter & Gamble Hygiene and Health Care Limited
Fundamentals for Procter & Gamble Hygiene and Health Care Limited
Regulatory Filings for Procter & Gamble Hygiene and Health Care Limited
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
Fundamentals for Procter & Gamble Hygiene and Health Care Limited
Business Operations:
Sector: Consumer DefensiveIndustry: Household & Personal Products
Procter & Gamble Hygiene and Health Care Limited engages in the manufacture and sale of branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Healthcare Products and Hygiene Products segments. The company provides health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also offers baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home care products; and oral care products. The company offers its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brand names. It sells its products through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Revenue projections:
Procter & Gamble Hygiene and Health Care Limited's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 33.903133 |
| debtToEquity | 0.221000 |
| earningsGrowth | 0.122000 |
| revenueGrowth | 0.011000 |
| grossMargins | 0.629480 |
| operatingMargins | 0.310880 |
| trailingEps | 220.170000 |
| forwardEps | 298.350000 |
PGHH's positive gross and operating margins highlight its profitability and operational efficiency. These strong margins demonstrate the company's ability to control costs while generating substantial revenue, contributing to a healthy financial performance.
With PGHH's forward EPS higher than its trailing EPS, the company is expected to be more profitable in the current financial year. This signals confidence in PGHH's growth potential, as improved earnings are forecasted compared to the prior year's performance.
Price projections:
PGHH's price projections have been steadily revised down, pointing to declining confidence in the company's outlook. This suggests that analysts are becoming more conservative in their expectations for PGHH's future performance.
Recommendation changes over time:
Analysts have shown a buy bias for PGHH, marking it as a favorable investment option. This could inspire investors to see PGHH as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
How Independent Directors Failed Rs 2,500 Crore in Value
India’s Stock Market May Be Sitting on a Trap